Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A
The skinny lineup of applications with US FDA user fee goal dates in July is heavy on incremental benefits from formulation technology, the Pink Sheet US FDA Performance Tracker’s User Fee Goal Date
Recent new drug and biologics license applications to the US FDA run the gamut from high-tech approaches to rare diseases to chemical modifications that open up possibilities in big psychiatry markets
IN VITRO DIAGNOSTICS Mergers & Acquisitions Institut Merieux bioMerieux SA BioFire Diagnostics Inc. Leading diagnostics firm bioMerieux SA (a division of Institut Merieux ) has agreed to acquir